Can high Sex Hormone-Binding Globulin (SHBG) levels cause atrophy in men?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

High SHBG and Testicular Atrophy in Men

High SHBG itself does not directly cause testicular atrophy in men; rather, elevated SHBG is part of a hormonal cascade in chronic liver disease where increased estrogen levels suppress the hypothalamic-pituitary axis, leading to hypogonadotropic hypogonadism, which then causes testicular atrophy. 1

The Mechanism: SHBG as a Marker, Not a Cause

The relationship between SHBG and testicular atrophy is indirect and context-dependent:

In Chronic Liver Disease (The Primary Context)

  • In men with advanced liver disease, testicular atrophy occurs through a specific hormonal pathway: low testosterone results from hypogonadotropic hypogonadism, with increased peripheral conversion of androgens to estrogen 1

  • SHBG rises in this setting (stimulated by elevated estrogens), and free testosterone declines partly from this observed rise in SHBG, though the reasons for SHBG elevation in chronic liver disease remain unclear 1

  • The critical pathophysiology: Elevated estrogen levels from portosystemic shunting suppress the hypothalamic-pituitary axis, which directly contributes to erectile dysfunction, oligospermia, testicular atrophy, and feminization 1

  • SHBG is a consequence, not the cause: As liver disease progresses from compensated to decompensated cirrhosis, SHBG levels ultimately decline despite ongoing testicular atrophy 1

In Healthy Men and Other Contexts

  • In healthy adult men and male newborns with an active hypothalamic-pituitary-gonadal axis, higher SHBG levels are not associated with lower non-SHBG-bound testosterone 2

  • SHBG shows remarkably wide variation (nearly 20-fold difference, range 6-109 nmol/L) in clinical populations, with mean SHBG of 27.7±13.3 nmol/L in men ≤54 years and 36.6±15.8 nmol/L in men ≥55 years 3

  • The traditional belief that SHBG decreases testosterone bioavailability may not hold in vivo: In the presence of an active HPG axis, SHBG levels barely influence non-SHBG-bound testosterone levels; the influence, if any, is actually positive 2

Clinical Implications

When to Suspect SHBG-Related Issues

Evaluate for underlying liver disease when encountering:

  • Testicular atrophy with elevated SHBG 1
  • Signs of feminization (gynecomastia) 1
  • Sexual dysfunction with hormonal abnormalities 1

Proper Testosterone Assessment

  • Measure morning total testosterone (8-10 AM) using an accurate assay in men with symptoms of hypogonadism 1

  • In men with total testosterone near the lower limit, determine free testosterone either by equilibrium dialysis or calculations using total testosterone, SHBG, and albumin 1

  • In obesity-related low testosterone, low SHBG is common: Men with obesity and hypogonadism often have low total testosterone due to low SHBG but may have normal free testosterone levels 1

Critical Pitfall to Avoid

Do not attribute testicular atrophy solely to elevated SHBG without investigating the underlying cause. The atrophy results from suppression of the hypothalamic-pituitary axis by elevated estrogens (in liver disease) or other causes of hypogonadotropic hypogonadism, not from SHBG elevation itself 1

Factors That Increase SHBG

Understanding what elevates SHBG helps identify the true pathology:

  • Drugs: anticonvulsants, estrogens, thyroid hormone 1
  • Hyperthyroidism 1
  • Hepatic disease 1
  • Aging 1
  • HIV/AIDS 1

Treatment Considerations

When testosterone replacement is indicated (confirmed hypogonadism with symptoms):

  • Testosterone administration decreases SHBG levels: In Klinefelter's patients, SHBG fell from 16.4±2 to 4.3±0.5 ng DHT bound/ml with testosterone enanthate treatment 4
  • This represents appropriate physiologic feedback, not a treatment complication 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.